MY17
Product Specifications
Target
Phosphatase
Related Pathways
Metabolism
Bioactivity
MY17 is an inhibitor of protein tyrosine phosphatase 1B (PTP1B) with an IC50 of 0.41±0.05 μM. It alleviates insulin resistance induced by palmitic acid (PA) by enhancing the expression of phosphorylated insulin receptor substrate (IRS1) and protein kinase B (AKT) . By binding to PTP1B, MY17 inhibits its activity, thereby improving insulin signaling and exhibiting antidiabetic properties. MY17 is useful in the study of type 2 diabetes.
Molecular Formula
C21H13N5O3S3
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15207904 1 Vial
Lentiviral mouse Defa22 shRNA (UAS) - Lentiviral mouse Defa22 shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details 
MBS2048795-01 0.1 mL
Cy3-Linked Polyclonal Antibody to Mannose Associated Serine Protease 2 (MASP2)
Sign In for Pricing
View Details MBS2048795-02 0.2 mL
Cy3-Linked Polyclonal Antibody to Mannose Associated Serine Protease 2 (MASP2)
Sign In for Pricing
View Details MBS2048795-03 0.5 mL
Cy3-Linked Polyclonal Antibody to Mannose Associated Serine Protease 2 (MASP2)
Sign In for Pricing
View Details